Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 18Observational 4

Sponsor

Cancer Type

Classical hematology 4Myeloid 1Gynecologic 1

Conditions

Venous Thromboembolism 4Neoplasms 3Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Ovarian Neoplasms 1Endometrial Neoplasms 1Embolism 1

Interventions

Rivaroxaban 8Surveys and Questionnaires 7Heparin, Low-Molecular-Weight 5apixaban 4fludarabine 3Blood Specimen Collection 3pegfilgrastim 2epoetin beta 2Therapeutics 2Polymerase Chain Reaction 2Piperacillin, Tazobactam Drug Combination 2Observation 2Microarray Analysis 2Melphalan 2Influenza Vaccines 2Immunoenzyme Techniques 2Flow Cytometry 2Epoetin Alfa 2Data Collection 2Dabigatran 2Biopsy 2ziprasidone 1ribociclib 1ravulizumab 1palbociclib 1oprelvekin 1iron isomaltoside 1000 1fludarabine phosphate 1edoxaban 1calcium heparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × apixaban × Classical hematology × Clear all
NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting
1 enrolled
Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

NCT06284343 2024-09-19

GynCAT

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
1,800 enrolled
Classical hematologyGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Vaginal Neoplasms, Endometrial Neoplasms, Venous Thromboembolism

NCT05461807 2022-10-26

H2H-OSCAR-US

Bayer

Completed
2,437 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

NCT03965741 2021-11-30

PRACTISE

Bayer

Completed
97,765 enrolled
Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡